Here's what you need to know about trading penny stocks on June 27th The post What to Know About Buying Penny Stocks on June 27th appeared first on Penny Stocks to Buy, Picks, News and Information | P
Shares of Evofem Biosciences Inc. EVFM, +26.95% soared 30.6% in trading on Friday, hours after the Supreme Court decision striking down Roe v. Wade was announced.
Evofem Biosciences Inc (NASDAQ: EVFM) shares are trading lower by 59.76% at $0.44 after the company announced the pricing of a roughly $26.6 million public offering. Evofem says the company intends to
Evofem Biosciences, Inc. (NASDAQ:EVFM ) Q1 2022 Results Conference Call May 4, 2022 4:30 PM ET Company Participants Amy Raskopf - Vice President-Investor Relations Saundra Pelletier - Chief Executive
SAN DIEGO , April 26, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced it will present new data from the Phase 3 AMPOWER Clinical Trial at the 2022 American College of
Evofem Biosciences, Inc. (NASDAQ:EVFM) with the stream of -2.05% also noticed, India Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) encountered a rapid change of 12.90% in the last hour of Thursday’s trading session. … The post Stock on fire: Evofem Biosciences, Inc. (NASDAQ:EVFM), Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) appeared first on Stocks Equity .
Shares of Evofem Biosciences (EVFM) are down 5% after the companys Q4 2021 results missed on the bottom line.
Evofem Biosciences press release (EVFM): Q4 GAAP EPS of -$0.33 misses by $0.10.Revenue of $3.57M (+2000.0% Y/Y) beats by $0.21M.Reduced net cash burn rate to $16.8 million in the…
/PRNewswire/ -- Evofem Biosciences, Inc. (Nasdaq: EVFM), a commercial stage biopharmaceutical company, today reported financial results for the three- and…
Evofem Biosciences' (EVFM) CEO Saundra Pelletier on Q4 2021 Results - Earnings Call Transcript

Evofem Biosciences Q4 2021 Earnings Preview (NASDAQ:EVFM)

10:35pm, Wednesday, 02'nd Mar 2022 Seeking Alpha
Evofem Biosciences (NASDAQ:EVFM) is scheduled to announce Q4 earnings results on Thursday, March 3rd, after market close.The consensus EPS Estimate is -$0.13 (+74.0% Y/Y) and the…
In recent trading session, Evofem Biosciences Inc. (NASDAQ:EVFM) saw 0.84 million shares changing hands at last check today with its beta currently measuring -0.33. Company’s recent per share price level of $0.48 trading at $0.0 or 0.27% at last check today assigns it a market valuation of $76.21M. That most recent trading price of EVFM’s … Evofem Biosciences Inc. (NASDAQ:EVFM) Is Looking Good Over The Long Term, Gained Nearly 16.44% Over A Month. Read More »
/PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a webcast and conference call to discuss financial results and business highlights for the…
The stock price of Evofem Biosciences Inc (NASDAQ: EVFM) increased by over 20% during intraday trading today. This is why it happened.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE